Capricor Therapeutics Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Capricor Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $54.11. The average 1-year stock price forecast is 113.62% higher than the current stock price, while the lowest is $38 (+50.02%) and the highest is $63 (+148.72%).

Price Target: $54.11 (+113.62%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$38	$54.11	$54	$63
Change	+50.02%	+113.62%	+113.19%	+148.72%

Analyst Ratings

The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	8	8	7	7
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Boobalan Pachaiyappan Roth MKM	Roth MKM	Buy Reiterates $38	Buy	Reiterates	$38	+50.02%	May 29, 2026
Matthew Venezia Alliance Global Partners	Alliance Global Partners	Buy Reiterates $51	Buy	Reiterates	$51	+101.34%	May 14, 2026
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $62	Buy	Maintains	$62	+144.77%	May 13, 2026
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $58	Buy	Reiterates	$58	+128.98%	May 13, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $60	Buy	Reiterates	$60	+136.87%	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

104.29M

Revenue Next Year

104.50M

from 104.29M

0.20%

from 104.29M

EPS This Year

-0.39

from -2.26

EPS Next Year

-0.76

from -0.39

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	244.90K	2.55M	25.18M	22.27M	-	104.29M
Gross Profit	-13.33M	-19.27M	-11.27M	-27.70M	-84.45M	83.43M
Gross Margin	-5,441.51%	-755.07%	-44.76%	-124.37%	-	80.00%
Operating Income	-20.94M	-29.70M	-24.08M	-42.56M	-108.14M	-32.97M
Net Income	-20.02M	-29.02M	-22.29M	-40.47M	-105.04M	-42.65M
EPS	-	-	-	-	-2.26	-0.39
Free Cash Flow	-10.62M	2.34M	-10.92M	-27.78M	-39.60M	90.00M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	213.3M
Avg	104.3M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	75.2%
Avg	0.2%
Low	-91.7%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.39
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-